000 03018nam a22004215i 4500
001 60591
005 20200226102628.0
007 cr nn 008mamaa
008 161031s2017 si | s |||| 0|eng d
020 _a9789811018787
_9978-981-10-1878-7
024 7 _a10.1007/978-981-10-1878-7
_2doi
035 _a(DE-He213)978-981-10-1878-7
050 4 _aRD592.5-596
072 7 _aMNN
_2bicssc
072 7 _aMED085010
_2bisacsh
082 0 4 _a617.48
_223
245 1 0 _aTreatment of Non-vitamin K Antagonist Oral Anticoagulants
_h[electronic resource] :
_bFor Prevention of Stroke /
_cedited by Masaaki Uno, Kuniaki Ogasawara.
264 1 _aSingapore :
_bSpringer Singapore :
_bImprint: Springer,
_c2017.
300 _aIX, 99 p. 31 illus., 13 illus. in color.
_bonline resource.
336 _atext
_btxt
_2rdacontent
337 _acomputer
_bc
_2rdamedia
338 _aonline resource
_bcr
_2rdacarrier
347 _atext file
_bPDF
_2rda
505 0 _a1.Intracranial Bleeding -- 2.Severity and Outcomes of Intracerebral Bleeding and Cardiac Cerebral Embolism -- 3.Influence for Intracranial Bleeding Surgery -- 4.New Approaches for the Secondary Prevention of Cryptogenic Stroke Using Non-Vitamin K Antagonist Oral Anticoagulants -- 5.Secondary Prevention of Cerebral Infarct: Verification of Appropriateness in Choices of Anticoagulant by Comparison of Current and previous Treatment Results -- 6.Putaminal Hemorrhage in Patients with Oral Anticoagulants -Course of Treatment and Results of Endoscopic Evacuation -- 7.Secondary Prevention of Stroke with Atrial Fibrillation by New Oral Anticoagulants -- 8.Causes and Outcome in Patients with Cerebral Hemorrhage Using Anticoagulated Drugs.
520 _aThis book describes new concepts and strategies for the clinical application of non-vitamin K antagonist oral anticoagulants (NOACs) for stroke. Although vitamin K antagonists have traditionally been used for the prevention of stroke, there are some problems associated with their use, such as the risk of intracranial hemorrhage, the need for dietary restrictions, and individual variability. Recently, NOACs have been introduced as alternatives to traditional anticoagulants and are becoming an option for treating stroke patients around the globe. However, their use is not without risk. Each chapter describes the successful use of NOACs for stroke patients and discusses their future impact from various points of view. The book is primarily written for neurosurgeons and neurologists but is also of interest to cardiologists involved in stroke treatment.
650 0 _aMedicine.
650 0 _aNeurosurgery.
650 1 4 _aMedicine & Public Health.
650 2 4 _aNeurosurgery.
700 1 _aUno, Masaaki.
_eeditor.
700 1 _aOgasawara, Kuniaki.
_eeditor.
710 2 _aSpringerLink (Online service)
773 0 _tSpringer eBooks
776 0 8 _iPrinted edition:
_z9789811018770
856 4 0 _uhttp://dx.doi.org/10.1007/978-981-10-1878-7
912 _aZDB-2-SME
999 _c8337
_d8337